IFN-γ- and IL-17-producing CD8+ T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity.
Takayuki OhkuriAkemi KosakaMaki IkeuraAndres M SalazarHideho OkadaPublished in: Journal for immunotherapy of cancer (2022)
Tc17-1 cells were equally effective as Tc1 cells when combined with poly-ICLC and peptide vaccine treatment.